Skip to main content

Table 2 Binary logistic regression analysis with odds ratio for in-hospital mortality

From: The effect of anti-coagulation dosage on the outcome of hospitalized COVID-19 patients in Ethiopia: a multi-center retrospective cohort study

 

Inpatient mortality, n (%)

Total

Crude OR (95% CI)

p-value

Adjusted OR (95% CI)

p-value

Age

 < 60 yrs

66 (24.1%)

274

    

 > 60 yrs

88 (44.4%)

198

2.52 (1.70–3.74)

 < 0.001

2.74 (1.60–4.69)

 < 0.001

Vaccine status

Not received

149 (33.7%)

442

    

Received at least 1 dose

5 (16.7%)

30

0.39 (0.15–1.05)

0.062

0.23 (0.07–0.84)

0.025

Hypertension

No

89 (27.4%)

304

    

Yes

65 (38.0%)

168

1.52 (1.03–2.27)

0.037

1.52 (0.87–2.65)

0.139

History of Stroke

No

148 (32.2%)

460

    

Yes

6 (50.0%)

12

2.11 (0.67–6.65)

0.203

2.44 (0.47–12.52)

0.286

Malignancy

No

148 (31.8%)

465

    

Yes

6 (85.7%)

7

12.85 (1.53–107.71)

0.019

19.70 (1.52–255.44)

0.023

COVID-19 Severity

Severe

25 (8.9%)

280

    

Critical

129 (67.2%)

192

20.56 (12.55–34.76)

 < 0.001

23.37 (13.45–40.62)

 < 0.001

Anticoagulation dosage

Prophylactic

66 (27.8%)

237

    

Therapeutic

88 (37.4%)

235

1.55 (1.05–2.29)

0.027

1.70 (1.02–2.84)

0.042